Artelo Biosciences (ARTL) Financials

$5.43

$-0.20 (-3.55%)

As on 11-Sep-2026 16:05EDT

Market cap

$3 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	11.07	11.40	10.11	9.93	10.29	10.29
Operating Profit (EBIT)	-11.07	-11.40	-10.11	-9.93	-10.29	-10.29
Other Income	--	--	--	--	--	--
Profit before Tax	-12.67	-12.88	-9.83	-9.29	-10.08	-10.08
Provision for Tax	--	--	--	--	-0.21	-0.21
Profit after Tax (Net Income)	-12.67	-12.88	-9.83	-9.29	-9.87	-10.08
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	--

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20
Shareholder's Funds	5.00	-1.27	2.86	11.75	19.40	19.40
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.01	0.03	0.07	--	0.02	0.02
Current Liabilities	1.46	4.04	1.77	1.29	1.00	1.00
Total Liabilities	7.91	2.80	4.70	13.04	20.42	20.42

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20
Non-Current Assets	2.09	2.11	2.14	2.06	2.10	2.10
Current Assets	4.37	0.70	2.56	10.98	18.32	18.32
Total Assets	7.91	2.80	4.70	13.04	20.42	20.42
Total Debt*	0.05	0.68	0.10	0.02	0.06	0.06
Net Current Assets	2.92	-3.35	0.79	9.69	9.69	9.69

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20
Cash From Operating Activities	--	-8.52	-8.35	-8.21	-8.01	-8.01
Cash Flow from Investing Activities	--	-0.06	7.77	3.51	--	2.96
Cash from Financing Activities	--	6.87	0.11	0.57	-0.04	-0.04
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20
Adjusted EPS ($)	-71.89	-49.19	-6.07	-5.83	--	-7.12
Cash EPS ($)	--	-49.19	-6.07	-5.83	--	-7.12
Adjusted Book Value ($)	--	--	1.76	7.37	--	13.70
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-32.54	-5.16	-5.15	--	-5.65
Free Cash Flow per Share ($)	--	-32.54	-5.16	-5.15	--	-5.65

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20
ROCE (%)	--	-1,088.21	-133.36	-59.47	-50.81	-51.88
ROE (%)	--	-1,625.11	-134.52	-59.63	-50.89	-51.97
ROA (%)	-140.92	-343.49	-110.77	-55.51	-48.35	-49.37
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	-25.49	-1.79	3.47	--	-38.25
Net Profit Growth (%)	-20.64	-31.07	-5.78	7.87	2.07	-35.58
EPS Growth (%)	-1,476.22	-7.11	-0.04	0.18	--	0.03
Book Value Growth (%)	2,131.23	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20
Price / Earnings	--	-0.02	-0.17	-0.24	--	-0.41
Price / Book Value	0.69	-0.25	0.60	0.19	--	0.21
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.22	-0.03	0.05	0.88	1.70	1.33
Close Price ($)	10.08	32.94	171.72	226.80	307.80	468.18
High Price ($)	772.20	772.20	283.50	567.00	699.84	1,794.07
Low Price ($)	9.27	31.05	147.42	186.30	225.18	385.56
Market Cap ($ Cr)	3.31	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20
Debt to Equity	--	-0.53	0.04	0.00	0.00	0.00
Short term debt to equity ratio	0.01	-0.51	0.01	0.00	0.00	0.00
Current Ratio	3.00	0.17	1.44	8.51	18.36	18.36
Quick Ratio	3.00	--	--	--	--	--
Interest Coverage	-19.50	-65.39	--	--	-2,057.40	-2,057.40

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Aug-23	Dec-22	Aug-22	Dec-21	Aug-21	Dec-20	Aug-20
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.